Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in child-pugh b cirrhosis.

[1]  P. Schirmacher,et al.  Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  R. Troisi,et al.  A Systematic Review and Meta-Analysis Comparing the Short- and Long-Term Outcomes for Laparoscopic and Open Liver Resections for Hepatocellular Carcinoma: Updated Results from the European Guidelines Meeting on Laparoscopic Liver Surgery, Southampton, UK, 2017 , 2018, Annals of Surgical Oncology.

[3]  P. Schirmacher,et al.  Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  Y. Maehara,et al.  Surgery for Hepatocellular Carcinoma in Patients with Child–Pugh B Cirrhosis: Hepatic Resection Versus Living Donor Liver Transplantation , 2018, World Journal of Surgery.

[5]  P. Schirmacher,et al.  EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. , 2018, Journal of hepatology.

[6]  Z. Morise.  Laparoscopic liver resection for the patients with hepatocellular carcinoma and chronic liver disease. , 2018, Translational gastroenterology and hepatology.

[7]  A. Tsung,et al.  Laparoscopic liver resection for hepatocellular carcinoma in early and advanced cirrhosis. , 2018, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[8]  H. Milionis,et al.  The role of liver resection in the management of intermediate and advanced stage hepatocellular carcinoma. A systematic review. , 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[9]  E. Felekouras,et al.  Ignore reality but not the consequences of its ignorance: Broaden guidelines in surgery of hepatocellular carcinoma , 2017, Hepatology.

[10]  L. Bolondi,et al.  Non-transplant therapies for patients with hepatocellular carcinoma and Child-Pugh-Turcotte class B cirrhosis. , 2017, The Lancet. Oncology.

[11]  G. Torzilli,et al.  Surgery and Hepatocellular Carcinoma , 2016, Liver Cancer.

[12]  G. Nunnari,et al.  Diagnostic and therapeutic management of hepatocellular carcinoma. , 2015, World journal of gastroenterology.

[13]  Ho‐Seong Han,et al.  Laparoscopic liver resection for hepatitis B and C virus-related hepatocellular carcinoma in patients with Child B or C cirrhosis. , 2015, Hepatobiliary surgery and nutrition.

[14]  G. Collins,et al.  Effect of Ebola Progression in Liberia , 2015, Annals of Internal Medicine.

[15]  X. Liang,et al.  Liver cirrhosis grading Child-Pugh class B: a Goliath to challenge in laparoscopic liver resection?-prior experience and matched comparisons. , 2015, Hepatobiliary surgery and nutrition.

[16]  Kuo-Hsin Chen,et al.  Can we expand the indications for laparoscopic liver resection? A systematic review and meta‐analysis of laparoscopic liver resection for patients with hepatocellular carcinoma and chronic liver disease , 2015, Journal of hepato-biliary-pancreatic sciences.

[17]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[18]  S. Kawasaki,et al.  Evidence‐based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH‐HCC Guidelines) , 2015, Hepatology research : the official journal of the Japan Society of Hepatology.

[19]  Lequn Li,et al.  Hepatic Resection as a Safe and Effective Treatment for Hepatocellular Carcinoma Involving a Single Large Tumor, Multiple Tumors, or Macrovascular Invasion , 2015, Medicine.

[20]  Y. Imai,et al.  JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan , 2014, Liver Cancer.

[21]  G. D'offizi,et al.  Laparoscopic liver resections in normal and cirrhotic livers: a retrospective analysis in a tertiary hepato-biliary unit. , 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[22]  L. Bolondi,et al.  Treatment of hepatocellular carcinoma in Child-Pugh B patients. , 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[23]  J. Barkun,et al.  The Comprehensive Complication Index: A Novel Continuous Scale to Measure Surgical Morbidity , 2013, Annals of surgery.

[24]  M. Choti,et al.  A Snapshot of the Effective Indications and Results of Surgery for Hepatocellular Carcinoma in Tertiary Referral Centers: Is It Adherent to the EASL/AASLD Recommendations? An Observational Study of the HCC East-West Study Group , 2013, Annals of surgery.

[25]  Y. Maehara,et al.  Surgical management of hepatocellular carcinoma in Child-Pugh class B cirrhotic patients: hepatic resection and/or microwave coagulation therapy versus living donor liver transplantation. , 2012, Annals of transplantation.

[26]  Lynette M. Smith,et al.  Comparison of outcomes of transplantation and resection in patients with early hepatocellular carcinoma: a meta-analysis. , 2012, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[27]  Jürgen Weitz,et al.  Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). , 2011, Surgery.

[28]  J. Bruix,et al.  Management of hepatocellular carcinoma: An update , 2011, Hepatology.

[29]  C. Porta,et al.  Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[30]  K. Suh,et al.  Prognostic factors affecting survival after recurrence in adult living donor liver transplantation for hepatocellular carcinoma , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[31]  Jeong Min Lee,et al.  Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma , 2010, Hepatology international.

[32]  K. Shirabe,et al.  Improved Results of a Surgical Resection for the Recurrence of Hepatocellular Carcinoma After Living Donor Liver Transplantation , 2010, Annals of Surgical Oncology.

[33]  M. Makuuchi,et al.  Risk factors and management of ascites after liver resection to treat hepatocellular carcinoma. , 2009, Archives of surgery.

[34]  M. Makuuchi,et al.  Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. , 2008, Gastroenterology.

[35]  G. Raj,et al.  How to build and interpret a nomogram for cancer prognosis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  Pere Ginès1.  Complications of Cirrhosis , 2008, Seminars in liver disease.

[37]  I. Bilbao,et al.  Recurrence of hepatocellular carcinoma after liver transplantation. , 2007, Transplantation proceedings.

[38]  M. Makuuchi,et al.  Staging of Hepatocellular Carcinoma: Assessment of the Japanese TNM and AJCC/UICC TNM Systems in a Cohort of 13,772 Patients in Japan , 2007, Annals of surgery.

[39]  R. Adams,et al.  Model for End-Stage Liver Disease (MELD) Predicts Nontransplant Surgical Mortality in Patients With Cirrhosis , 2005, Annals of surgery.

[40]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[41]  E. Abdalla,et al.  Resection Prior to Liver Transplantation for Hepatocellular Carcinoma , 2003, Annals of surgery.

[42]  L. Ellis,et al.  Simplified staging for hepatocellular carcinoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  J. Bruix,et al.  Intention‐to‐treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation , 1999, Hepatology.

[44]  O. Farges,et al.  Laparoscopy extends the indications for liver resection in patients with cirrhosis , 1999, The British journal of surgery.

[45]  V. Mazzaferro,et al.  Pattern and management of recurrent hepatocellular carcinoma after liver transplantation. , 1998, Journal of hepato-biliary-pancreatic surgery.

[46]  D. Hosmer,et al.  A comparison of goodness-of-fit tests for the logistic regression model. , 1997, Statistics in medicine.

[47]  J. Bruix,et al.  Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. , 1996, Gastroenterology.

[48]  ndrea,et al.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.

[49]  T. Starzl,et al.  Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation , 1991, Cancer.

[50]  F. Harrell,et al.  Regression modelling strategies for improved prognostic prediction. , 1984, Statistics in medicine.

[51]  R. Pugh,et al.  Transection of the oesophagus for bleeding oesophageal varices , 1973, The British journal of surgery.

[52]  M. Dumont,et al.  European Association for the Study of the Liver , 1971 .

[53]  H. Edmondson,et al.  Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies , 1954, Cancer.

[54]  A. Jemal,et al.  Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.

[55]  R. Santambrogio,et al.  Hepatic resection for hepatocellular carcinoma in patients with Child-Pugh's A cirrhosis: is clinical evidence of portal hypertension a contraindication? , 2013, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[56]  E. Hatano,et al.  Results of hepatic resection for hepatocellular carcinoma invading major portal and/or hepatic veins. , 2003, Surgical oncology clinics of North America.

[57]  J. Bosch,et al.  Complications of cirrhosis. I. Portal hypertension. , 2000, Journal of hepatology.

[58]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.